Search research articles
Contact Us
Filters
Showing results (21-30 of 529) with videos related to
Page
of 53
Sort By:
Respirology (Carlton, Vic.)
|
September 30, 2010
Systemic corticosteroid and reactivation of chronic hepatitis B
Ching-Lung Lai, Man-Fung Yuen
Annals of Internal Medicine
|
July 4, 2007
The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points
Ching-Lung Lai, Man-Fung Yuen
Cold Spring Harbor Perspectives in Medicine
|
June 3, 2015
Management of chronic hepatitis B in patients from special populations
Ching-Lung Lai, Man-Fung Yuen
Methods in Molecular Medicine
|
February 6, 2004
Specific considerations in the design of hepatitis B virus clinical studies in the far East
Man-Fung Yuen, Ching-Lung Lai
Journal of Gastroenterology
|
September 18, 2016
Nonalcoholic fatty liver disease in Asia: emerging perspectives
Wai-Kay Seto, Man-Fung Yuen
Hepatology (Baltimore, Md.)
|
March 28, 2013
Reply: To PMID 22806323
Ching-Lung Lai, Man-Fung Yuen
Expert Review of Anti-Infective Therapy
|
August 19, 2005
Telbivudine: an upcoming agent for chronic hepatitis B
Man-Fung Yuen, Ching-Lung Lai
Annals of Internal Medicine
|
April 2, 2008
What is the best end point for hepatitis B treatment?
Ching-Lung Lai, Man-Fung Yuen
The Journal of Antimicrobial Chemotherapy
|
March 5, 2003
Current and future antiviral agents for chronic hepatitis B
Man-Fung Yuen, Ching-Lung Lai
The New England Journal of Medicine
|
December 5, 2008
Chronic hepatitis B--new goals, new treatment
Ching-Lung Lai, Man-Fung Yuen
Page
of 53
Search research articles
Search
Showing results (21-30 of 529) with videos related to
Sort By:
Page
of 53
Respirology (Carlton, Vic.)
|
September 30, 2010
Systemic corticosteroid and reactivation of chronic hepatitis B
Ching-Lung Lai, Man-Fung Yuen
Annals of Internal Medicine
|
July 4, 2007
The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points
Ching-Lung Lai, Man-Fung Yuen
Cold Spring Harbor Perspectives in Medicine
|
June 3, 2015
Management of chronic hepatitis B in patients from special populations
Ching-Lung Lai, Man-Fung Yuen
Methods in Molecular Medicine
|
February 6, 2004
Specific considerations in the design of hepatitis B virus clinical studies in the far East
Man-Fung Yuen, Ching-Lung Lai
Journal of Gastroenterology
|
September 18, 2016
Nonalcoholic fatty liver disease in Asia: emerging perspectives
Wai-Kay Seto, Man-Fung Yuen
Hepatology (Baltimore, Md.)
|
March 28, 2013
Reply: To PMID 22806323
Ching-Lung Lai, Man-Fung Yuen
Expert Review of Anti-Infective Therapy
|
August 19, 2005
Telbivudine: an upcoming agent for chronic hepatitis B
Man-Fung Yuen, Ching-Lung Lai
Annals of Internal Medicine
|
April 2, 2008
What is the best end point for hepatitis B treatment?
Ching-Lung Lai, Man-Fung Yuen
The Journal of Antimicrobial Chemotherapy
|
March 5, 2003
Current and future antiviral agents for chronic hepatitis B
Man-Fung Yuen, Ching-Lung Lai
The New England Journal of Medicine
|
December 5, 2008
Chronic hepatitis B--new goals, new treatment
Ching-Lung Lai, Man-Fung Yuen
Page
of 53